Episode 089: Prostate Cancer Series, Pt. 6- Treatment for Met. Castrate Sensitive Prostate Cancer

The Fellow on Call: The Heme/Onc Podcast

Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

8M ago

MP3•Episode home

This week, we continue our discussion about metastatic castrate sensitive prostate cancer. Spoiler alert: there is not good guidance or biomarkers that help us pick one regimen over another. In this episode, we go through the data, our critical appraisal of the data, and some things to consider when selecting one regimen over another.

As a refresher, be sure to check out our Pharmacology Episode and our introductory episodes, as we will be building on these concepts.

Content:

- Approach to metastatic disease

- Who needs germline testing?

- History of prostate cancer therapy

- Selecting doublet vs. triplet therapy

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

121 episodes

#Ronak Mistry #Rouleaux University Medical Center #Science #Fitness #Biology #Podcasting Education #Medicine #Lung Cancer